Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EyeQue has developed a suite of at-home vision testing devices and digital platforms that allow users to self-administer refractive measurements and monitor key vision markers such as visual acuity, color vision, and contrast sensitivity. Their technology has been validated in clinical studies to provide results comparable to professional autorefractors within a small margin of error. The company’s products are FDA class I registered medical devices intended for screening purposes only—not diagnosis—and support telehealth integration with eye care professionals. Over 100,000 users in more than 160 countries have used EyeQue’s solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EyeQue.